Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Steris Corp (STE)

Steris Corp (STE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Steris Corp 70 Sir John Rogerson`s Quay Dublin L2 D02 R296 IRL

P: 353-1232-2000

Description:

Steris Plc provide infection prevention, contamination control, microbial reduction, and procedural support products and services for healthcare, pharmaceutical, scientific, research, industrial and governmental customers. The Company's operating segments consists of Healthcare, Life Sciences and STERIS Isomedix Services. Healthcare segment manufactures and sells capital equipment, accessory, consumables, information support and service solutions to healthcare providers, including acute care hospitals and surgery and gastrointestinal centers. Life Sciences segment manufactures and sells a range of capital equipment, formulated cleaning chemistries and service solutions to pharmaceutical companies and private and public research facilities. Isomedix segment sells an array of contract processing services as well as laboratory testing services. Steris Plc, formerly known as STERIS Corporation, is headquartered in Leicester, United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 18,607,916
Shares Outstanding, K 85,377
Annual Sales, $ 3,108 M
Annual Net Income, $ 397,400 K
Last Quarter Sales, $ 873,530 K
Last Quarter Net Income, $ 88,850 K
60-Month Beta 0.56
% of Insider Shareholders 1.14%
% of Institutional Shareholders 94.03%
Float, K 84,404
% Float 98.86%

Growth:

1-Year Return 35.26%
3-Year Return 86.68%
5-Year Return 200.75%
5-Year Revenue Growth 38.81%
5-Year Earnings Growth 82.01%
5-Year Dividend Growth 60.20%

Per-Share Information:

Most Recent Earnings 1.63 on 05/18/21
Next Earnings Date 08/09/21
Earnings Per Share ttm 6.15
EPS Growth vs. Prev Qtr -5.78%
EPS Growth vs. Prev Year -0.61%
Annual Dividend Rate, $ 1.60
Annual Dividend Yield 0.74%
Most Recent Dividend 0.400 on 05/27/21
Next Ex-Dividends Date 05/27/21
Dividend Payable Date 06/25/21
Dividend Payout Ratio 25.31%
Most Recent Split 2-1 on 08/25/98

STE Ratios

Ratio
Price/Earnings ttm 35.25
Price/Earnings forward 23.65
Price/Earnings to Growth N/A
Return-on-Equity % 14.17%
Return-on-Assets % 8.81%
Profit Margin % 12.79
Net Margin % 9.36
Debt/Equity 0.42
Price/Sales 5.96
Price/Cash Flow 24.69
Price/Book 4.70
Book Value/Share 45.59
Interest Coverage 14.92

STE Dividends

Date Value
05/27/21 $0.4000
02/23/21 $0.4000
11/23/20 $0.4000
08/26/20 $0.4000
06/11/20 $0.3700
02/24/20 $0.3700
11/25/19 $0.3700
09/09/19 $0.3700
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar